IP Library › Granted Patent US 12,383,762
Granted Patent B2
US 12,383,762 · App. 18/500,753 · Granted Aug 12, 2025

Fiducial marker for oncological and other procedures

Inventors: Alex Vayser (Mission Viejo, CA); Sunny Mitchell (Westport, CT); Henry Jay Lee (Chappaqua, NY); Joseph Guido (San Francisco, CA)
Assignee: Videra Surgical Inc.
A61N5/1007A61N5/1049G06T7/0012A61B2017/00004A61B2090/3908A61B2090/3966A61B2090/3991A61N2005/1008A61N2005/1058A61N2005/1062G06T2207/10081G06T2207/30068G06T2207/30096G06T2207/30204
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,383,762
App. No.
18/500,753
Granted
Aug 12, 2025
Kind
B2
Abstract

A method and apparatus for marking a target with a radiopaque marker is disclosed. The method may include providing a radiopaque filament and inserting at least portion of the radiopaque filament into tissue. The filament may extend continuously and at last partially around a perimeter of the target so that the filament is disposed in a plurality of surgical planes to demarcate the target with the radiopaque maker.

Claims (19)

1. A radiopaque marker, comprising:

a flexible radiopaque filament comprising a loop configured to be disposed at adjacent tissue,

wherein the loop forms a spring element configured to expand from a collapsed configuration to an expanded configuration that fills a void or a surgical cavity surrounded by the tissue.

2. The radiopaque marker of claim 1 , wherein the radiopaque marker is configured to delineate an interior surface of a surgical cavity surrounded by the tissue when viewed with radiographic imaging.

3. The radiopaque marker of claim 1 , wherein the loop is a closed, continuous loop.

4. The radiopaque marker of claim 1 , wherein the loop is a square loop, a rectangular loop, or a circular loop.

5. The radiopaque marker of claim 1 , wherein the flexible radiopaque filament comprises two ends, and wherein the two ends are coupled together.

6. The radiopaque marker of claim 1 , further comprising a coating disposed on the flexible radiopaque filament.

7. The radiopaque marker of claim 6 , wherein the coating comprises a hydrogel.

8. The radiopaque marker of claim 6 , wherein the coating is configured to increase friction of the flexible radiopaque filament thereby resisting movement of the radiopaque marker relative to the tissue.

9. The radiopaque marker of claim 6 , wherein the coating causes the radiopaque marker to be visible under magnetic resonance imaging (MRI) or ultrasound.

10. The radiopaque marker of claim 6 , wherein the coating is discontinuous on the flexible radiopaque filament.

11. The radiopaque marker of claim 1 , further comprising an anchor element coupled to the flexible radiopaque filament, the anchor element configured to prevent movement of the radiopaque marker relative to the tissue.

12. The radiopaque marker of claim 1 , wherein the flexible radiopaque filament is bioresorbable or wherein the flexible radiopaque filament is configured to remain permanently in the tissue.

13. The radiopaque marker of claim 1 , wherein the flexible radiopaque filament has length greater than 1 mm.

14. The radiopaque marker of claim 1 , wherein the radiopaque marker further comprises a second loop configured to be disposed in the surgical cavity in the tissue, wherein the second loop is formed from the flexible radiopaque filament, or wherein the second loop is formed from a second flexible radiopaque filament.

15. The radiopaque marker of claim 14 , wherein the loop is disposed in a first plane and the second loop is disposed in a second plane different than the first plane.

16. The radiopaque marker of claim 1 , wherein the flexible radiopaque filament comprises a plurality of segments, and wherein at least some of the plurality of segments are configured to move independently of one another.

17. The radiopaque marker of claim 1 , wherein the flexible radiopaque filament comprises an elongate filament combined with a radiopaque material.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2023
From: VAYSER, ALEX; MITCHELL, SUNNY; LEE, HENRY JAY; GUIDO, JOSEPH
To: VIDERA SURGICAL INC.
Reel/Frame 065682/0212 →
Continuity (7)
Continuation 18355984 · Jul 20, 2023
Continuation 18166393 · Feb 8, 2023
Continuation 17817115 · Aug 3, 2022
Continuation 16791410 · Feb 14, 2020
Provisional Application 62943464 · Dec 4, 2019
Provisional Application 62805595 · Feb 14, 2019
Related Publication 20240058623A1 · Feb 22, 2024
References Cited (106)
US 5610967A · Moorman et al. · 1997 [cited by applicant]
US 6174330B1 · Stinson · 2001 [cited by applicant]
US 6436026B1 · Sioshansi et al. · 2002 [cited by applicant]
US 7083641B2 · Stinson et al. · 2006 [cited by applicant]
US 9199092B2 · Stubbs et al. · 2015 [cited by applicant]
US 11464998B2 · Vayser et al. · 2022 [cited by applicant]
US 11602642B2 · Vayser et al. · 2023 [cited by applicant]
US 11819709B2 · Vayser et al. · 2023 [cited by applicant]
US 12109432B2 · Vayser et al. · 2024 [cited by applicant]
US 20020082683A1 · Stinson et al. · 2002 [cited by applicant]
US 20040006255A1 · Sajo et al. · 2004 [cited by applicant]
US 20040116802A1 · Jessop et al. · 2004 [cited by applicant]
US 20040242953A1 · Good · 2004 [cited by applicant]
US 20050020916A1 · MacFarlane · 2005 [cited by examiner]
US 20060015138A1 · Gertner · 2006 [cited by examiner]
US 20060079770A1 · Sirimanne et al. · 2006 [cited by applicant]
US 20060116713A1 · Sepetka et al. · 2006 [cited by applicant]
US 20070276494A1 · Ferree · 2007 [cited by applicant]
US 20070288082A1 · Williams · 2007 [cited by applicant]
US 20080021313A1 · Eidenschink et al. · 2008 [cited by applicant]
US 20100222672A1 · Macfarlane et al. · 2010 [cited by applicant]
US 20110125253A1 · Casanova et al. · 2011 [cited by applicant]
US 20120330153A1 · Sirimanni et al. · 2012 [cited by applicant]
US 20130172931A1 · Gross et al. · 2013 [cited by applicant]
US 20130178948A1 · Tseng et al. · 2013 [cited by applicant]
US 20130180966A1 · Gross et al. · 2013 [cited by applicant]
US 20130184577A1 · Corbitt, Jr. et al. · 2013 [cited by applicant]
US 20140180065A1 · Garcia · 2014 [cited by applicant]
US 20140257378A1 · Norton et al. · 2014 [cited by applicant]
US 20150148837A1 · Shinar et al. · 2015 [cited by applicant]
US 20150297316A1 · Grinstaff et al. · 2015 [cited by applicant]
US 20150327861A1 · Jackson et al. · 2015 [cited by applicant]
US 20160022415A1 · Lebovic et al. · 2016 [cited by applicant]
US 20160296765A1 · Corbitt, Jr. et al. · 2016 [cited by applicant]
US 20170188983A1 · Jackson et al. · 2017 [cited by applicant]
US 20180085184A1 · Bolan et al. · 2018 [cited by applicant]
US 20180263706A1 · Averbuch · 2018 [cited by applicant]
US 20180344429A1 · Stewart · 2018 [cited by applicant]
US 20190110859A1 · Baker · 2019 [cited by examiner]
US 20200261742A1 · Vayser et al. · 2020 [cited by applicant]
US 20220184418A1 · Arazi et al. · 2022 [cited by applicant]
US 20230010957A1 · Vayser et al. · 2023 [cited by applicant]
US 20230134658A1 · Vayser et al. · 2023 [cited by applicant]
US 20230218924A1 · Vayser et al. · 2023 [cited by applicant]
US 20230364444A1 · Vayser et al. · 2023 [cited by applicant]
US 20240358471A1 · Vayser et al. · 2024 [cited by applicant]
EP 0894503A2 · 1999 [cited by applicant]
FR 3093908 · 2020 [cited by applicant]
WO WO2007045913A2 · 2007 [cited by applicant]
WO WO2018097891A1 · 2018 [cited by applicant]
WO WO2020168181A1 · 2020 [cited by applicant]
WO WO2023070084A1 · 2023 [cited by applicant]
WO 2024226500 · 2025 [cited by applicant]
“International Application Serial No. PCT US2024 025825, International Search Report mailed Oct. 16, 2024”, 4 pgs. [cited by applicant]
“International Application Serial No. PCT US2024 025825, Written Opinion mailed Oct. 16, 2024”, 5 pgs. [cited by applicant]
“European Application Serial No. 20754954.4, Response filed Dec. 16, 2024 to Communication Pursuant to Article 94(3) EPC mailed Aug. 14, 2024”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/160,229, Final Office Action mailed Jun. 15, 2021”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/160,229, Non Final Office Action mailed Dec. 28, 2020”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/160,229, Non Final Office Action mailed Dec. 29, 2021”, 22 pgs. [cited by applicant]
“U.S. Appl. No. 16/160,229, Notice of Allowance mailed May 9, 2022”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/160,229, Response filed Mar. 23, 2022 to Non Final Office Action mailed Dec. 29, 2021”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/160,229, Response filed Apr. 28, 2021 to Non Final Office Action mailed Dec. 28, 2020”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 16/160,229, Response filed Nov. 12, 2021 to Final Office Action mailed Jun. 15, 2021”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 16/791,410, Corrected Notice of Allowability mailed Sep. 14, 2022”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/791,410, Examiner Interview Summary mailed Jul. 25, 2022”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/791,410, Non Final Office Action mailed May 27, 2022”, 18 pgs. [cited by applicant]
“U.S. Appl. No. 16/791,410, Notice of Allowance mailed Jul. 29, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/791,410, Response filed Jul. 18, 2022 to Non Final Office Action mailed May 27, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/817,115, Notice of Allowance mailed Feb. 2, 2023”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/817,115, Preliminary Amendment Filed Oct. 3, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/854,597, Non Final Office Action mailed Jun. 22, 2023”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 18/166,393, Non Final Office Action mailed Jun. 16, 2023”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 18/166,393, Notice of Allowance mailed Jul. 6, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/166,393, Preliminary Amendment Mar. 20, 2023”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 18/166,393, Response filed Jun. 22, 2023 to Non Final Office Action mailed Jun. 16, 2023”, 9 pgs. [cited by applicant]
“Core Needle Biopsy of the Breast”, American Cancer Society, [Online] Retrieved from the Internet: <URL: https://web.archive.org/web/20190508015215/https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-d… [cited by applicant]
“European Application Serial No. 20754954.4, Communication Pursuant to Rules 161(2) and 162 EPC mailed Oct. 1, 2021”, 8 pgs. [cited by applicant]
“European Application Serial No. 20754954.4, Extended European Search Report mailed Oct. 19, 2022”, 4 pgs. [cited by applicant]
“European Application Serial No. 20754954.4, Response filed May 18, 2023 to Extended European Search Report mailed Oct. 19, 2022”, 8 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/018276, International Preliminary Report on Patentability mailed Aug. 26, 2021”, 9 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/018276, International Search Report mailed Apr. 28, 2020”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2020/018276, Written Opinion mailed Apr. 28, 2020”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2022/078503, International Search Report mailed Mar. 14, 2023”, 4 pgs. [cited by applicant]
“International Application Serial No. PCT/US2022/078503, Invitation to Pay Additional Fees mailed Jan. 3, 2023”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2022/078503, Written Opinion mailed Mar. 14, 2023”, 6 pgs. [cited by applicant]
“Surgical Suturing Techniques Mastery Guide”, The Apprentice Doctor, [Online] Retrieved from the Internet: <URL: https://www.theapprenticedoctor.com/complete-guide-to-mastering-suturing-techniques/>, (Mar. 11, 2015), 21… [cited by applicant]
Ingle, Nilesh P, et al., “Mechanical Performance and Finite Element Analysis of Bi-directional Barbed Sutures”, North Carolina State University, (Aug. 2003), 1-126. [cited by applicant]
Jin-Cheol, Kim, et al., “Comparison of tensile and knot security properties of saurgical sutures”, Mater Sci: Mater Med, 18, (Year: 2007), (Jun. 14, 2007), 2363-2369. [cited by applicant]
Nimmy, Francis K, et al., “In Situ lodination Cross-Linking of Silk for Radio-Opaque Antimicrobial Surgical Sutures”, ACS Biomaterials Science & Engineering, (Jan. 11, 2016), 188-196. [cited by applicant]
Patel, Jaison, et al., “A technique for marking oncological breast tissue specimens”, Annals of Medicine and Surgery, 7, (2016), 7-8. [cited by applicant]
Shah, Stuti R, et al., “Effect of Barium Sulphate As A Filler In Thermoplastic Polymer For Medical Applications”, Medical Plastics Data Service, [Online] Retrieved from the Internet: <URL: http://www.medicalplasticsindi… [cited by applicant]
“U.S. Appl. No. 18/355,984, Non Final Office Action mailed Mar. 25, 2024”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 18/355,984, Response filed Apr. 3, 2024 to Non Final Office Action mailed Mar. 25, 2024”, 8 pgs. [cited by applicant]
“International Application Serial No. PCT US2022 078503, International Preliminary Report on Patentability mailed May 2, 2024”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/355,984, Final Office Action mailed Jul. 5, 2024”, 14 pgs. [cited by applicant]
“International Application Serial No. PCT US2024 025825, Invitation to Pay Additional Fees mailed Jul. 19, 2024”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 18/355,984, Response filed Aug. 13, 2024 to Final Office Action mailed Jul. 5, 2024”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 18/355,984, Examiner Interview Summary mailed Aug. 15, 2024”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 18/355,984, Notice of Allowance mailed Aug. 27, 2024”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/048,554, Restriction Requirement mailed Sep. 3, 2024”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 18/048,554, Response filed Sep. 6, 24 to Restriction Requirement mailed Sep. 3, 2024”, 8 pgs. [cited by applicant]
“European Application Serial No. 20754954.4, Communication Pursuant to Article 94(3) EPC mailed Aug. 14, 2024”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 18/048,554, Non Final Office Action mailed Sep. 23, 2024”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 18/048,554, Response filed Mar. 12, 2025 to Non Final Office Action mailed Sep. 23, 2024”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 18/048,554, Final Office Action mailed Mar. 26, 2025”, 16 pgs. [cited by applicant]
“European Application Serial No. 20754954.4, Communication Pursuant to Article 94(3) EPC mailed Apr. 9, 2025”, 8 pgs. [cited by applicant]